OMOP Concept 36036857
luspatercept 75 MG Injectable Solution [Reblozyl] by Celgene
StandardDrugRxNorm ExtensionOMOP5046857Marketed Product
Maps from
0
Descendants
0
Valid from
17 Jun 2021
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(19)Roll up to these when you need a wider cohort.
- 1luspatercept 75 MG Injectable Solution
- 1luspatercept 75 MG Injectable Solution [Reblozyl]
- 2luspatercept-aamt 75 MG
- 2luspatercept-aamt 75 MG [Reblozyl]
- 2luspatercept Injectable Solution
- 2luspatercept Injectable Solution [Reblozyl]
- 3luspatercept
- 3luspatercept; parenteral
- 4Other antianemic preparations
- 4Recombinant medication
- 4TGF-beta inhibitor
- 5Erythrocyte growth factor
- 5Medications by manufacturing method
- 5OTHER ANTIANEMIC PREPARATIONS
- 6ANTIANEMIC PREPARATIONS
- 6Hematopoietic growth factor
- 7BLOOD AND BLOOD FORMING ORGANS
- 7Growth factor
- 8Supportive medication
Get this concept via the API
Resolve luspatercept 75 MG Injectable Solution [Reblozyl] by Celgene - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/36036857?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card